Literature DB >> 7824446

The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation.

G Krikun1, C J Lockwood, X X Wu, X D Zhou, S Guller, C Calandri, A Guha, Y Nemerson, J H Rand.   

Abstract

We evaluated the histological and ultrastructural localization of the potent anticoagulant protein, annexin V, at the light and electron microscopic levels, using immunohistochemistry and an immunogold method. Annexin V was found to localize to the microvillar surface of the villous syncytiotrophoblasts. Isolated villous-derived trophoblasts were then utilized to evaluate the expression of annexin 1 protein mRNA in response to syncytialization in vitro, as well as to exposure to adenylate cyclase and protein kinase C agonists. Levels of immunoreactive annexin V released into the conditioned media and associated with cell protein were assessed by ELISA while levels of annexin V mRNA were evaluated by Northern analysis. No significant change in either media or cell-associated annexin V concentrations were detected over time in culture or in response to 1.5 mM 8-bromo-cyclic-adenosine-monophosphate (8-b-cAMP) or 0.15 nM phorbol ester myristic acid (PMA). These results indicate that annexin V is ideally positioned to inhibit intervillous thrombosis and maintain the fluidity of the intervillous circulation. Moreover, the absence of trophoblast annexin V regulation by intracellular second messenger regulators suggests that this crucial placental anticoagulant factor is constitutively produced.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824446     DOI: 10.1016/s0143-4004(05)80407-2

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  22 in total

1.  Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia.

Authors:  S Guller; Z Tang; Y Y Ma; S Di Santo; R Sager; H Schneider
Journal:  Placenta       Date:  2010-11-11       Impact factor: 3.481

Review 2.  Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

3.  Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome.

Authors:  Beverley J Hunt; Xiao-Xuan Wu; Bas de Laat; Alan A Arslan; Sara Stuart-Smith; Jacob H Rand
Journal:  Am J Obstet Gynecol       Date:  2011-06-15       Impact factor: 8.661

4.  Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.

Authors:  Xiao-Xuan Wu; Seth Guller; Jacob H Rand
Journal:  Am J Obstet Gynecol       Date:  2011-06-24       Impact factor: 8.661

5.  The haplotype M2 of the ANXA5 gene is not associated with antitrophoblast antibodies.

Authors:  Nina Rogenhofer; Laura Engels; Nadja Bogdanova; Frank Tüttelmann; Arseni Markoff; Christian J Thaler
Journal:  J Assist Reprod Genet       Date:  2013-03-27       Impact factor: 3.412

6.  Assessment of M2/ANXA5 haplotype as a risk factor in couples with placenta-mediated pregnancy complications.

Authors:  Nina Rogenhofer; Lara R M Nienaber; Lea C Amshoff; Nadia Bogdanova; David Petroff; Peter Wieacker; Christian J Thaler; Arseni Markoff
Journal:  J Assist Reprod Genet       Date:  2017-09-13       Impact factor: 3.412

7.  Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications.

Authors:  Federico Aranda; Sebastián Udry; Silvia Perés Wingeyer; Lea Christina Amshoff; Nadja Bogdanova; Peter Wieacker; José Omar Latino; Arseni Markoff; Gabriela de Larrañaga
Journal:  J Assist Reprod Genet       Date:  2018-03-01       Impact factor: 3.412

8.  Antiphospholipid antibodies associated with implantation failure after IVF/ET.

Authors:  C B Coulam; B D Kaider; A S Kaider; P Janowicz; R G Roussev
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

9.  Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Anthony S Quinn; Anthony W Ashton; Pojen P Chen; James J Hathcock; Harry A M Andree; Douglas J Taatjes
Journal:  Blood       Date:  2009-11-30       Impact factor: 22.113

10.  Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Anthony S Quinn; Pojen P Chen; Keith R McCrae; Edwin G Bovill; Douglas J Taatjes
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.